| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/17/2009 | CN101456906A Rice protein OsSRM and coding gene and application thereof |
| 06/17/2009 | CN101456905A Bacteria 5 type secretory protein and construction method and application thereof |
| 06/17/2009 | CN101456904A Rhamnose bacterium lacticum Pr2 peptide and coding gene thereof, separation method and application |
| 06/17/2009 | CN100501400C Methods of protecting against radiation damage using alpha thymosin |
| 06/17/2009 | CN100500853C Fusion protein for secretion of protein of interest in supernatant of bacterial culture |
| 06/17/2009 | CN100500846C Human cytokine as ligand of zalpha receptor and use thereof |
| 06/17/2009 | CN100500658C Pharmaceutical composition of male sexual dysfunction |
| 06/17/2009 | CA2610324A1 Stem cells methods, technologies, vertical processes |
| 06/16/2009 | US7547821 Methods for the production of insulin in plants |
| 06/16/2009 | US7547820 Method for altering the nutritional content of plant seed |
| 06/16/2009 | US7547773 Binding site amino acid sequences for use as targeting agents in immunotherapeutics; antitumor agents; which conforms to human leukocyte antigen (HLA) motifs; immunogens; cytotoxic T lymphocytes; comprises proteases; prostate cancer |
| 06/16/2009 | US7547771 Biallelic tumor markers for use as diagnostic/prognostic indicators of cell proliferative disorders |
| 06/16/2009 | US7547770 Colostral fractionation process |
| 06/16/2009 | US7547769 Immunomodulatory constructs and their uses |
| 06/16/2009 | US7547768 Anti-TAT 113 antibodies |
| 06/16/2009 | US7547767 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| 06/16/2009 | US7547766 Anti-tango294 antibodies and uses thereof |
| 06/16/2009 | US7547764 OrfF and OrfF′ polypeptides, nucleic acid molecules encoding the polypeptides and applications thereof |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547762 T24 antigen for immunodiagnosis of Taenia solium cysticercosis |
| 06/16/2009 | US7547761 For isolating low molecular weight peptides from animal tissue; prevention of initial dissolution of higher molecular weight fraction proteins by in situ denaturation within the tissue, by an organic solvent (preferably ethanol), prior to aqueous extraction |
| 06/16/2009 | US7547760 Using the anti-SHP2 peptides and SEBA compounds (4-(2-sulfaminoethyl)benzoic acid) reverses cell transformation and induces remission of preformed tumors in vivo demonstrating a possible treatment for cancer; phosphotyrosyl phosphatase |
| 06/16/2009 | US7547759 Stimulating cytotoxic T-lymphocytes |
| 06/16/2009 | US7547726 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure |
| 06/16/2009 | US7547682 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 06/16/2009 | US7547681 Surface receptor antigen vaccines |
| 06/16/2009 | US7547675 Chemically modified polypeptides |
| 06/16/2009 | US7547544 Hybridoma cell line for production of immunoglobulins specific to g protein coupled receptor for use in prevention and treatment of cell proliferative disorders |
| 06/16/2009 | US7547531 L-amino acid producing microorganism which has been modified to inactive the fimH gene, and a method for producing I-amino acid |
| 06/16/2009 | US7547529 Formation of a by-product polypeptide containing an O-acetylserine residue in place of a serine residue by adding histidine, methionine or glycine to the medium in culturing transformed cells |
| 06/16/2009 | US7547528 Expression vector comprising nucleotide sequences coding coral fluorescent protein for use as reporter molecules in genetic engineering |
| 06/16/2009 | US7547523 Drug screening for agonists and antagonists of the mammalian histamine receptor; for inflammation, asthma, and allergy, atopic dermatitis, stroke, myocardial infection, migraine, COPD, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and psoriasis |
| 06/16/2009 | US7547521 Heteromultimeric ion channel receptor and uses thereof |
| 06/16/2009 | US7547517 complexes, expression vectors and host cells transformed or transfected with nucleic acid molecules encoding MAGE-C2; for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring |
| 06/16/2009 | US7547515 Eating disorders; measuring obesity receptor (ObR) gene expression by detecting mRNA transcripts |
| 06/16/2009 | US7547509 Viricide polypeptide having >70% sequence identity to native cyanovirin-N and having strategic cysteine and arginine replacements is covalent modified by water-soluble Polyoxyethylene Glycol to extend half-life, reduce toxicity, immunogenicity, improve pharmacokinetics, bioavailability; envelope viruses |
| 06/16/2009 | US7547506 Using 6-carboxyfluorescein labeled mycobacterial amino acid sequences to detect infection; veterinary medicine |
| 06/16/2009 | US7547442 Newcastle disease virus infectious clones, vaccines and new diagnostic assays |
| 06/16/2009 | US7547441 PAI-2 conjugates for the treatment and imaging of cancer |
| 06/16/2009 | US7547440 Derived from Japanese cypress pollen allergen; stimulates lymphocytes; reduce symptoms of pollinosis; immunotherapy and diagnosing spring tree pollinosis (Hay fever) |
| 06/16/2009 | US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide |
| 06/16/2009 | US7547437 Kidney or liver fibrosis; using antagonist against the mitogenic vascular endothelial growth factors (zvegf3), such as a monoclonal antibody against zvegf3, receptor binding variants, or antisense agents; antagonist of zvegf3 inhibits cell proliferation; humanized, single-chain antibody |
| 06/16/2009 | CA2399900C Dehiscence gene and methods for regulating dehiscence |
| 06/16/2009 | CA2326327C Recombinant adeno-associated virus vector encoding alpha-1-antitrypsin serum protein |
| 06/16/2009 | CA2319437C Methods and reagents for decreasing allergic reactions |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2255101C Immunoreactive regions of glycoprotein gpii of varicella zoster virus (vzv) |
| 06/16/2009 | CA2158322C Immunoconjugate comprising an anti-egf receptor antibody and interleukin-8 |
| 06/11/2009 | WO2009073808A2 Compositions and methods to modulate cell membrane resealing |
| 06/11/2009 | WO2009073460A2 Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 for ocular neuroprotection |
| 06/11/2009 | WO2009073399A2 Engineering enzymatically susceptible proteins |
| 06/11/2009 | WO2009073253A1 Methods for preventing or treating complications of airway control devices |
| 06/11/2009 | WO2009073115A1 Combination vegfr2 therapy with mtor inhibitors |
| 06/11/2009 | WO2009073104A2 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 06/11/2009 | WO2009072883A1 Methods for generating marker free transgenic plants |
| 06/11/2009 | WO2009072609A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 06/11/2009 | WO2009072608A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 06/11/2009 | WO2009072508A1 Medical composition for implantation |
| 06/11/2009 | WO2009071914A2 Mutant proteins and methods for producing them |
| 06/11/2009 | WO2009071886A1 Fviii peptides and their use in tolerising haemophiliacs |
| 06/11/2009 | WO2009071864A1 Method |
| 06/11/2009 | WO2009071679A1 Novel aav vector and uses thereof |
| 06/11/2009 | WO2009071672A1 Method for controlling insect populations |
| 06/11/2009 | WO2009071659A1 Trophic factor for the treatment of retinal degenerative diseases |
| 06/11/2009 | WO2009071530A1 Fungal pepc inhibitor |
| 06/11/2009 | WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof |
| 06/11/2009 | WO2009054878A8 Compositions and methods for the treatment of neoplasia |
| 06/11/2009 | WO2009052184A3 Compositions comprising optimized her1 and her3 multimers and methods of use thereof |
| 06/11/2009 | WO2009048658A9 Optimized dengue virus entry inhibitory peptide (dn81) |
| 06/11/2009 | WO2009041832A3 Vaccines and vaccine components for inhibition of microbial cells |
| 06/11/2009 | WO2009037183A3 Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia |
| 06/11/2009 | WO2009030978A3 Conformers of bacterial adhesins |
| 06/11/2009 | WO2009027752A3 Process for producing hepcidin |
| 06/11/2009 | WO2009021063A3 Composition and method of use for hcv immunization |
| 06/11/2009 | WO2008128526A3 Use of egfl7 for stem cell modulation |
| 06/11/2009 | WO2008005631A3 Genes encoding chavicol/eugenol synthase from the creosote bush larrea tridentata |
| 06/11/2009 | WO2006138689A3 Improved amino acid and metabolite biosynthesis |
| 06/11/2009 | WO2004013092A3 Beta-alanine n-methyltransferase |
| 06/11/2009 | WO2003038038A3 16 human secreted proteins |
| 06/11/2009 | WO2003006615A3 Method of making fgf-12 and kgf-2 |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | WO2002089727A3 Methods of using cytokine c17 |
| 06/11/2009 | WO2002058484A3 Kolla 2-desiccated avian sternal cartilage powder |
| 06/11/2009 | WO2002040636A3 Modification of a plant disease resistance gene specificity and method for engineering altered specificity |
| 06/11/2009 | WO2002040632A3 Creation and identification of proteins having new dna binding specificities |
| 06/11/2009 | US20090151019 Late blight resistance gene from wild potato |
| 06/11/2009 | US20090151017 altering cellulose synthase concentration in the cell wall and thereby altering plant stalk quality for improved standability or silage |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090151012 Animal Model Having a Chimeric Human Liver and Susceptible to Human Hepatitis C Virus Infection |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149634 Porous body comprising apatite/collagen composite fibers and its production method |
| 06/11/2009 | US20090149633 Artificial diet for lepidopteran insects and production method thereof, lepidopteran insect and production method thereof, and biological material |
| 06/11/2009 | US20090149632 Antibacterial peptide |
| 06/11/2009 | US20090149631 Methods and compositions for protein labeling using lipoic acid ligases |
| 06/11/2009 | US20090149630 Stabilized Alpha Helical Peptides and Uses Thereof |
| 06/11/2009 | US20090149629 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders; (cyclo 31-34)[Ac-Pro4,D-Phe12,Nle18,21,Glu31,Lys34]-sucker urotensin |
| 06/11/2009 | US20090149628 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 06/11/2009 | US20090149413 RORS as Modifiers of the p21 Pathway and Methods of Use |
| 06/11/2009 | US20090149406 Plasmid PXL3179 or NV1FGF |